Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma
Clinical trial NCT02433834 · COMPLETED
Trial details
- NCT number
- NCT02433834
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-27
- Primary completion
- 2016-03-26
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.